Top Markets
Coin of the day
Aroa Biosurgery Limited Aroa Biosurgery Limited

Aroa Biosurgery Limited

ARX
Rang in Aktien #20200
Aroa Biosurgery Limited operates as a regenerative medicine company dedicated... Aroa Biosurgery Limited operates as a regenerative medicine company dedicated to the development, production, and global distribution of medical solutions for wound and tissue repair. The firm innovatively utilizes extracellular matrix (ECM) technology, with its market presence spanning the United States and international territories. Its product line encompasses Endoform Natural and Endoform Antimicrobial Restorative Bioscaffold, tailored for managing both acute and chronic wounds. Additionally, the company offers Myriad Matrix, an engineered ECM device designed for soft tissue repair, reinforcement, and complex wound treatment, along with Myriad Morcells, a powdered version of Myriad Matrix serving similar soft tissue and complex wound applications. Rounding out its offerings are Reinforced Bioscaffolds, a specialized surgical product employed in ventral hernia repair and abdominal wall reconstruction. Founded in 2007, Aroa Biosurgery Limited is headquartered in Auckland, New Zealand.
Aktienkurs
$0.39848591
Marktkapitalisierung
$137.67M
Veränderung (1 Tag)
-1.74%
Veränderung (1 Jahr)
-3.96%
Land
NZ
Handel Aroa Biosurgery Limited (ARX)

Kategorie

Aktien-Split-Historie für Aroa Biosurgery Limited (ARX)
Die Aktie Aroa Biosurgery Limited (Symbol: ARX) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Aug 25, 2026 statt.
Eine ARX-Aktie, die vor dem Aug 25, 2026 gekauft wurde, entspricht heute 0 ARX-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.
Aktiensplits ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Aktiensplits Kumulierter Multiplikator Land
9 x285
US
9 x162
US
7 x127
IE
2 x4
US
0 -
DE